Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-22-046707

Options or other derivatives

  • General Counsel and Secretary acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KASINGER JAMES R. General Counsel and Secretary 2022-08-16 Grant or award · Restricted Stock Units +20,000 20,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…